Schedule 13G ownership disclosure

RAPT THERAPEUTICS INC

Common Stock, $0.0001 par value · CUSIP: 75382E109

Event date: 2024-12-27

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Medicxi IV LP

    Shares: 21,977,977 · Class: 16.6%

  • Medicxi Co-Invest IV LP

    Shares: 374,023 · Class: 0.3%

  • Medicxi IV GP Limited

    Shares: 22,352,000 · Class: 16.9%

  • Medicxi Ventures Management (Jersey) Limited

    Shares: 22,352,000 · Class: 16.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-001724
Form type
SCHEDULE 13G
Filer
Medicxi IV LP
CIK
CIK 1929290
Filed
Jan 06, 2025
Reporting period
Dec 27, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub